Hope for a Mad-Cow Therapy Is Seen in German Clinical Trial

Article Abstract:

Asta Medica, which is a unit of Frankfurt, Germany-based Degussa-Huels AG, is studying flupirtine as a therapy for mad-cow disease. The clinical trial is focusing on the human form of the disease, which is called Creutzfeldt-Jakob disease.

Germany, Central Nervous System Prep, Central nervous system agents, Bovine spongiform encephalopathy, Creutzfeldt-Jakob disease, Asta Medica AG, Degussa-Huels AG

---

New protocol: how drug's rebirth as treatment for cancer fueled price rises

Article Abstract:

Biotechnology company Celgene Corp. relaunched the drug thalidimide in 1998 to treat leprosy and severe weight loss caused by AIDS. At that time, the company priced the medication reasonably to avoid protests from AIDS activists. When Thalidimide was later reborn again, this time as a treatment for cancer patients, the company tripled its cost knowing that they were a lot less likely to receive negative publicity regarding a cancer drug.

Europe, Acquisitions & mergers, Netherlands, Government regulation, Science & research, Commodity & service prices, Management dynamics, Executive changes & profiles, Anticancer Drugs, Chemotherapeutic Drugs, Anticancer Immunostimulant Preps, Research, Management, Officials and employees, Mergers, acquisitions and divestments, Prices and rates, Company acquisition/merger, Political aspects, Drug therapy, Medical care, Cost of, Health care costs, Licensing, certification and accreditation, Antineoplastic agents, Company Profile, Company business management, Leprosy, Thalidomide (Medication), Company pricing policy, Jackson, John (English boxer), AIDS treatment, Antimitotic agents, Celgene Corp., CELG, Barer, Sol, Thalomid (Medication)

---

Drug maker cuts risk by buying others' pills

Article Abstract:

To reduce research and development costs, pharmaceutical companies are buying, testing, and marketing experimental drugs developed by smaller pharmaceutical and biotech firms. Article discusses Shire PLC's management, earnings, and production and marketing strategies.

Forecasts, trends, outlooks, Marketing procedures, United Kingdom, Forecasts and trends, Marketing, Market trend/market analysis, Company marketing practices, Shire Pharmaceuticals Group PLC, Pharmaceutical research, Industry forecasts

Similar abstracts:

• Abstracts: Pirelli wants to revisit terms for takeover of Telecom Italia. Pirelli rolls out new web strategy
• Abstracts: The Spanish market for ice cream, yoghurt and chilled desserts. The Italian market for ice cream, yoghurt and chilled desserts
• Abstracts: Accor's Shares Climb as Investors Cheer Its Sale of European Stake. NH Hoteles of Spain reports 1999 net income surged 150%
• Abstracts: Tempestuous times increase risks for unwary mutual-fund investors. Accenture will launch Jan.1
• Abstracts: Cybersquatting: European companies are not amused by spread of bogus coporate sites. Retailers' ultimate cool tool: the mobile phone

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.